Follow-up: Tirzepatide's shorter half-life and its one practical consequence

Where I part company with post #25, and it is a narrow parting.

Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a finer gradation. That does not mean you cannot escalate on a coarser schedule if that suits you — the published schedule is not a lower bound.

Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak. Different populations, different durations, different baseline characteristics; the only fair comparison is a head-to-head one.

I would hold that lightly until someone with a larger sample weighs in.

Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They depend entirely on where the threshold was drawn.

Not a strong opinion, just a consistent one.

Narrowing post #76, because the general version has more than one answer.

Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They depend entirely on where the threshold was drawn.

I would rather say I do not know than round it up to an answer.

Agreed on all of that, and I have nothing to add to it.

Injection-site reactions were reported at a low but non-zero rate across the trials. The practical point is that a reaction at one site does not predict a reaction at the next, and rotating properly makes the question moot.

I had read the opposite somewhere and cannot now find where, which tells me something.

Where I part company with post #122, and it is a narrow parting.

Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks rather than four. That is a real difference from semaglutide and it is small enough that the weekly schedule is unaffected.

The literature is thinner on this than the confidence in the thread implies.